Streetbeat News

Products Services

FBLG

FibroBiologics has announced preliminary proof-of-concept results for its novel artificial thymus organoid technology, which could have significant implications for regenerative medicine and immune system therapies.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:32 pm

TEM

UTHR

Tempus has announced a collaboration with United Therapeutics to study the use of AI in detecting patients at risk for pulmonary hypertension. This partnership aims to leverage Tempus' AI capabilities to improve patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:32 pm

EPOW

Sunrise New Energy has secured a new client who will place a monthly order of 300 tons of anode materials.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:30 pm

FTDR

Frontdoor has signed an exclusive agreement with Moen to install the Flo Smart Water Monitor and Shutoff, Water Shut-Off Valve. Financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:30 pm

AMZN

Amazon.com Inc (NASDAQ:AMZN) shares are trading slightly higher as the company announces details of its 10th Prime Day event, scheduled for July 16 and 17. The event will feature millions of exclusive deals across more than 35 categories, with special promotions involving Megan Thee Stallion. Last year's Prime Day saw U.S. online sales climb 6.1% year-over-year to $12.7 billion.

Portfolio Pulse from Adam Eckert

June 25, 2024 | 1:26 pm

NVDA

RXRX

Recursion Pharmaceuticals (NASDAQ: RXRX) shares are trading higher after CEO Chris Gibson's CNBC interview and upcoming presentation with Nvidia's Jensen Huang. The discussion focused on AI's role in drug discovery, highlighting Recursion's BioHive-2 supercomputer built with Nvidia's help. Needham analyst Gil Blum reiterated a Buy rating for RXRX with a $17 price target.

Portfolio Pulse from Adam Eckert

June 25, 2024 | 1:23 pm

HES

IYE

NVDA

XLE

XOM

Exxon Mobil Corporation (NYSE:XOM) and its partners, including Hess Corporation (NYSE:HES) and CNOOC, have generated $6.33 billion from their oil venture in Guyana, with Exxon reporting a net profit of $2.9 billion. The consortium's net margin of 56% surpasses that of NVIDIA Corporation (NASDAQ:NVDA). The venture's revenue rose by 23% in 2023, and production is expected to increase with the addition of three more vessels. Investors can gain exposure to Exxon via Energy Select Sector SPDR Fund (NYSE:XLE) and iShares U.S. Energy ETF (NYSE:IYE).

Portfolio Pulse from Lekha Gupta

June 25, 2024 | 1:22 pm

ARM

AVGO

DELL

NVDA

QCOM

SMCI

Nvidia Corp (NASDAQ:NVDA) experienced a significant stock price drop after briefly becoming the world's most valuable company. This decline also impacted other tech companies linked to the AI boom, including Super Micro Computer Inc (NASDAQ:SMCI), Dell Technologies Inc (NYSE:DELL), Arm Holdings Plc (NASDAQ:ARM), Qualcomm Inc (NASDAQ:QCOM), and Broadcom Inc (NASDAQ:AVGO). Despite the drop, experts believe Nvidia's performance will continue to be strong for the next 18-24 months, making it a good time to buy the dip. Geopolitical tensions between the U.S. and China could negatively affect semiconductor stocks.

Portfolio Pulse from Anusuya Lahiri

June 25, 2024 | 1:22 pm

CING

Cingulate has completed twelve required registration batches for its ADHD drug CTx-1301, marking a significant milestone in its development. The company is now preparing a New Drug Application for submission to the FDA for marketing clearance.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:22 pm

FROG

JFrog announced its acquisition of Qwak AI to enhance the transition of AI models from development to production. No financial terms were disclosed. JFrog also reiterated its financial guidance for Q2 and FY24 provided on May 9, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 1:21 pm